Sponsor:
Hartford Hospital
Code:
NCT02890199
Conditions
Pelvic Organ Prolapse
Eligibility Criteria
Sex: Female
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Bupivacaine liposomal
Lidocaine
Brief summary:
Conditions
Pelvic Organ Prolapse
Study ID
NCT02890199
Start date
Oct, 2016
Status verified date
Oct, 2016
Completion date
Jul, 2017
Anticipated
Primary completion date
Jun, 2017
Anticipated
Eligibility Criteria
Sex: Female
Age: 18 - 70+
Healthy Volunteers: Not accepted
Enrollment
30 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
active comparator: Lidocaine group
experimental: Bupivacaine liposomal group
Interventions
Bupivacaine liposomal
Lidocaine
Primary outcome measure
Central contacts
David M. O'Sullivan, PhD
david.o'sullivan@hhchealth.orgLocations
Hartford Hospital, Urogynecology Division
Recruiting
Hartford, Connecticut, United States, 06106
Contacts
Sponsor
Hartford Hospital
Last update posted
Oct 12, 2016
Last verified
Oct, 2016
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Hartford Hospital on 2016-10-12.